Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Predictors of driving in individuals with relapsing-remitting multiple sclerosis.
Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis.
Concepts for regulation of axon integrity by enwrapping glia.
Characterization of Axonal Disease in Patients with Multiple Sclerosis Using High-Gradient-Diffusion MR Imaging.
Novel Agents for Relapsing Forms of Multiple Sclerosis.
miR-17-92 cluster targets Phosphatase and Tensin Homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammation.
Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15.
Atorvastatin: Multiple Sclerosis.
Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.
Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitors Remyelinate the Brain and Rescue Behavioral Deficits following Radiation.
Rituximab combination therapy in relapsing multiple sclerosis.
Saffold Virus Type 3 (SAFV-3) Persists in HeLa Cells.
The utility of cerebrospinal fluid analysis in patients with multiple sclerosis.
The myelin mutants as models to study myelin repair in the leukodystrophies.
7 Tesla MRI demonstrates vascular pathology in Balo's concentric sclerosis.
Genetic inactivation of the adenosine A(2A) receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis.
Re-expression of N-cadherin in remyelinating lesions of experimental inflammatory demyelination.
Effects of yoga interventions on fatigue: a meta-analysis.
Vitamin d and multiple sclerosis.
[Retinal vasculitis as manifestation of multiple sclerosis.]
Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study.
Adverse socioeconomic position during the life course is associated with multiple sclerosis.
Murine experimental autoimmune encephalomyelitis is diminished by treatment with the angiogenesis inhibitors b20-4.1.1 and angiostatin (k1-3).
Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis.
Retraction notice: Language abilities of patients with primary progressive multiple sclerosis: A preliminary group and case investigation.

Pages